Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rasmussen

Showing results (1011-1020 of 1,306) with videos related to

Pageof 131
Sort By:
Plos Pathogens|August 26, 2016
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infectionC da Cunha-Bang, N Kirkby, M Sønderholm, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2002
Barriers to successful dietary control among pregnant women with phenylketonuriaAmanda Savage Brown, Paul M Fernhoff, Susan E Waisbren, et al.
Plos Pathogens|July 3, 2015
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
Stem Cell Research|September 7, 2016
Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3Susanne K Hansen, Tina C Stummann, Helena Borland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2006
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorderBenjamin D Greenberg, Donald A Malone, Gerhard M Friehs, et al.
Vaccine|September 15, 2007
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeysShisong Jiang, Robert A Rasmussen, Katrina M Nolan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second EditionEric A Storch, Joseph F McGuire, Monica S Wu, et al.
Journal of Neurointerventional Surgery|January 9, 2024
Treatment outcomes for ARUBA-eligible brain arteriovenous malformations: a comparison of real-world data from the NVQI-QOD AVM registry with the ARUBA trialAnas Alrohimi, Rebecca L Achey, Nicolas Thompson, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|September 9, 2014
Developmental outcomes in young children born to mothers with West Nile illness during pregnancyPatricia A Sirois, Gabriella Pridjian, Scott McRae, et al.
Pageof 131

Showing results (1011-1020 of 1,306) with videos related to

Sort By:
Pageof 131
Plos Pathogens|August 26, 2016
Correction: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 4, 2013
The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infectionC da Cunha-Bang, N Kirkby, M Sønderholm, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 8, 2002
Barriers to successful dietary control among pregnant women with phenylketonuriaAmanda Savage Brown, Paul M Fernhoff, Susan E Waisbren, et al.
Plos Pathogens|July 3, 2015
HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days--Implications for HIV RemissionMykola Pinkevych, Deborah Cromer, Martin Tolstrup, et al.
Stem Cell Research|September 7, 2016
Induced pluripotent stem cell - derived neurons for the study of spinocerebellar ataxia type 3Susanne K Hansen, Tina C Stummann, Helena Borland, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 21, 2006
Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorderBenjamin D Greenberg, Donald A Malone, Gerhard M Friehs, et al.
Vaccine|September 15, 2007
Live attenuated Listeria monocytogenes expressing HIV Gag: immunogenicity in rhesus monkeysShisong Jiang, Robert A Rasmussen, Katrina M Nolan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second EditionEric A Storch, Joseph F McGuire, Monica S Wu, et al.
Journal of Neurointerventional Surgery|January 9, 2024
Treatment outcomes for ARUBA-eligible brain arteriovenous malformations: a comparison of real-world data from the NVQI-QOD AVM registry with the ARUBA trialAnas Alrohimi, Rebecca L Achey, Nicolas Thompson, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|September 9, 2014
Developmental outcomes in young children born to mothers with West Nile illness during pregnancyPatricia A Sirois, Gabriella Pridjian, Scott McRae, et al.
Pageof 131